These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
232 related items for PubMed ID: 18582952
1. Behavioral and pathological outcomes in MOG 35-55 experimental autoimmune encephalomyelitis. Jones MV, Nguyen TT, Deboy CA, Griffin JW, Whartenby KA, Kerr DA, Calabresi PA. J Neuroimmunol; 2008 Aug 13; 199(1-2):83-93. PubMed ID: 18582952 [Abstract] [Full Text] [Related]
2. Opioid growth factor suppresses expression of experimental autoimmune encephalomyelitis. Zagon IS, Rahn KA, Bonneau RH, Turel AP, McLaughlin PJ. Brain Res; 2010 Jan 15; 1310():154-61. PubMed ID: 19931226 [Abstract] [Full Text] [Related]
3. T cell and antibody responses in remitting-relapsing experimental autoimmune encephalomyelitis in (C57BL/6 x SJL) F1 mice. Zhang GX, Yu S, Gran B, Li J, Calida D, Ventura E, Chen X, Rostami A. J Neuroimmunol; 2004 Mar 15; 148(1-2):1-10. PubMed ID: 14975581 [Abstract] [Full Text] [Related]
4. Spinal cord histopathology of MOG peptide 35-55-induced experimental autoimmune encephalomyelitis is time- and score-dependent. Recks MS, Addicks K, Kuerten S. Neurosci Lett; 2011 May 02; 494(3):227-31. PubMed ID: 21406210 [Abstract] [Full Text] [Related]
5. Neuropathic pain behaviours in a chronic-relapsing model of experimental autoimmune encephalomyelitis (EAE). Olechowski CJ, Truong JJ, Kerr BJ. Pain; 2009 Jan 02; 141(1-2):156-64. PubMed ID: 19084337 [Abstract] [Full Text] [Related]
6. An MHC anchor-substituted analog of myelin oligodendrocyte glycoprotein 35-55 induces IFN-gamma and autoantibodies in the absence of experimental autoimmune encephalomyelitis and optic neuritis. Ford ML, Evavold BD. Eur J Immunol; 2004 Feb 02; 34(2):388-97. PubMed ID: 14768043 [Abstract] [Full Text] [Related]
7. The MAO inhibitor phenelzine improves functional outcomes in mice with experimental autoimmune encephalomyelitis (EAE). Musgrave T, Benson C, Wong G, Browne I, Tenorio G, Rauw G, Baker GB, Kerr BJ. Brain Behav Immun; 2011 Nov 02; 25(8):1677-88. PubMed ID: 21723939 [Abstract] [Full Text] [Related]
10. VEGF and angiogenesis in acute and chronic MOG((35-55)) peptide induced EAE. Roscoe WA, Welsh ME, Carter DE, Karlik SJ. J Neuroimmunol; 2009 Apr 30; 209(1-2):6-15. PubMed ID: 19233483 [Abstract] [Full Text] [Related]
11. Distinct pathological patterns in relapsing-remitting and chronic models of experimental autoimmune enchephalomyelitis and the neuroprotective effect of glatiramer acetate. Aharoni R, Vainshtein A, Stock A, Eilam R, From R, Shinder V, Arnon R. J Autoimmun; 2011 Nov 30; 37(3):228-41. PubMed ID: 21752599 [Abstract] [Full Text] [Related]
12. A novel protective model against experimental allergic encephalomyelitis in mice expressing a transgenic TCR-specific for myelin oligodendrocyte glycoprotein. Mendel I, Natarajan K, Ben-Nun A, Shevach EM. J Neuroimmunol; 2004 Apr 30; 149(1-2):10-21. PubMed ID: 15020060 [Abstract] [Full Text] [Related]
14. Overexpression of CNTF in Mesenchymal Stem Cells reduces demyelination and induces clinical recovery in experimental autoimmune encephalomyelitis mice. Lu Z, Hu X, Zhu C, Wang D, Zheng X, Liu Q. J Neuroimmunol; 2009 Jan 03; 206(1-2):58-69. PubMed ID: 19081144 [Abstract] [Full Text] [Related]
15. Opioid growth factor arrests the progression of clinical disease and spinal cord pathology in established experimental autoimmune encephalomyelitis. Campbell AM, Zagon IS, McLaughlin PJ. Brain Res; 2012 Sep 07; 1472():138-48. PubMed ID: 22820301 [Abstract] [Full Text] [Related]
19. Methylprednisolone induces reversible clinical and pathological remission and loss of lymphocyte reactivity to myelin oligodendrocyte glycoprotein in experimental autoimmune encephalomyelitis. Chan J, Ban EJ, Chun KH, Wang S, McQualter J, Bernard C, Toh BH, Alderuccio F. Autoimmunity; 2008 Aug 07; 41(5):405-13. PubMed ID: 18568646 [Abstract] [Full Text] [Related]
20. Soluble egg antigen from Schistosoma japonicum modulates the progression of chronic progressive experimental autoimmune encephalomyelitis via Th2-shift response. Zheng X, Hu X, Zhou G, Lu Z, Qiu W, Bao J, Dai Y. J Neuroimmunol; 2008 Feb 07; 194(1-2):107-14. PubMed ID: 18207251 [Abstract] [Full Text] [Related] Page: [Next] [New Search]